Announcements Trials
Browse Landscape

Phase

Phase 1 9Phase 2 7Phase 1/2 4Phase NA 3Phase 3 2Phase EARLY_PHASE1 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 23Genitourinary 22Lymphoid 18Sarcoma 13CNS 13Other hematologic neoplasm 12Thoracic 9Head & Neck 9Gynecologic 9Breast 9Tumor-Agnostic 2Myeloid 2Dermatologic 2Other solid neoplasm 1

Conditions

Skin Neoplasms 1Melanoma 1Lymphedema 1

Interventions

Dacarbazine 27Nivolumab 26pembrolizumab 22Ipilimumab 203-ingenyl angelate 11Interferon-alpha 10Imiquimod 10Temozolomide 9trametinib 8Vemurafenib 8Photochemotherapy 8Aminolevulinic Acid 8methyl 5-aminolevulinate 7dabrafenib 7cemiplimab 7aldesleukin 7Introns 7Surgical Procedures, Operative 6Radiotherapy 6Interferon alpha-2 6Fluorouracil 6Paclitaxel 5Melphalan 5Interleukin-2 5Cisplatin 5Chemotherapy, Adjuvant 5talimogene laherparepvec 4binimetinib 4Specimen Handling 4Opdualag 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Radiation × Dermatologic × Clear all
NCT00193895 2018-04-06

Post-operative Concurrent Chemo-radiotherapy Versus Post-operative Radiotherapy for Cancer of the Head and Neck

Trans Tasman Radiation Oncology Group

Phase 3 Completed
321 enrolled
Dermatologic

Skin Neoplasms

NCT00287196 2013-06-25

Immediate Radiotherapy or Observation After Surgery for Melanoma Involving Lymph Nodes

Trans Tasman Radiation Oncology Group

Phase 3 Completed
250 enrolled
Dermatologic

Lymphedema, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡